A detailed history of Nisa Investment Advisors, LLC transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 758 shares of LGND stock, worth $84,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
758
Previous 756 0.26%
Holding current value
$84,562
Previous $63,000 19.05%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$82.7 - $110.11 $165 - $220
2 Added 0.26%
758 $75,000
Q2 2024

Jul 19, 2024

BUY
$68.53 - $87.91 $1,027 - $1,318
15 Added 2.02%
756 $63,000
Q1 2024

May 01, 2024

BUY
$68.64 - $89.2 $1,029 - $1,338
15 Added 2.07%
741 $54,000
Q4 2023

Jan 25, 2024

BUY
$49.57 - $72.63 $495 - $726
10 Added 1.4%
726 $51,000
Q3 2023

Nov 02, 2023

SELL
$58.86 - $72.67 $470 - $581
-8 Reduced 1.1%
716 $42,000
Q2 2023

Aug 11, 2023

BUY
$69.53 - $79.33 $4,171 - $4,759
60 Added 9.04%
724 $52,000
Q3 2022

Nov 07, 2022

BUY
$0.01 - $107.56 $0 - $1,290
12 Added 1.84%
664 $58,000
Q2 2022

Aug 03, 2022

SELL
$74.52 - $117.06 $7,452 - $11,706
-100 Reduced 13.3%
652 $58,000
Q1 2022

Apr 29, 2022

BUY
$94.99 - $151.56 $3,514 - $5,607
37 Added 5.17%
752 $85,000
Q1 2021

Apr 26, 2021

BUY
$99.52 - $215.83 $19,904 - $43,166
200 Added 38.83%
715 $109,000
Q4 2020

Jan 25, 2021

SELL
$80.55 - $106.05 $48,330 - $63,630
-600 Reduced 53.81%
515 $51,000
Q3 2020

Oct 20, 2020

BUY
$89.56 - $126.72 $48,362 - $68,428
540 Added 93.91%
1,115 $106,000
Q2 2020

Jul 27, 2020

SELL
$68.28 - $123.65 $65,207 - $118,085
-955 Reduced 62.42%
575 $64,000
Q1 2020

Apr 17, 2020

BUY
$63.37 - $107.88 $17,109 - $29,127
270 Added 21.43%
1,530 $111,000
Q4 2019

Jan 17, 2020

BUY
$96.94 - $113.59 $19,388 - $22,718
200 Added 18.87%
1,260 $131,000
Q3 2019

Oct 17, 2019

BUY
$86.25 - $120.16 $82,800 - $115,353
960 Added 960.0%
1,060 $106,000
Q4 2018

Jan 17, 2019

SELL
$128.36 - $272.13 $993,891 - $2.11 Million
-7,743 Reduced 98.72%
100 $14,000
Q3 2018

Oct 16, 2018

BUY
$211.18 - $274.49 $1.62 Million - $2.11 Million
7,693 Added 5128.67%
7,843 $2.15 Million
Q2 2018

Jul 19, 2018

BUY
$150.77 - $207.98 $7,538 - $10,399
50 Added 50.0%
150 $31,000
Q1 2018

Apr 10, 2018

SELL
$138.63 - $182.62 $6,931 - $9,131
-50 Reduced 33.33%
100 $17,000
Q3 2017

Oct 13, 2017

BUY
$120.91 - $137.94 $18,136 - $20,691
150
150 $20,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.88B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.